Bright Minds Biosciences Inc. ( DRUG) - Stock Earnings
DRUG Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -2.9 million USD | — USD |
| 2025Q4 | -5.5 million USD | — USD |
| 2026Q1 | -7.6 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
DRUG Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -5.4 million USD | — USD |
| 2024 | -2.1 million USD | — USD |
| 2025 | -8.8 million USD | — USD |
| 2026 Est. | — | — |
DRUG
Price: $58.78
52 week price:
Earnings Per Share: -2.49 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 141500
Market Capitalization: 574.9 million